علاج التصلب اللويحي مع آفات الرنين المغناطيسي الدماغية النشطة والانتكاسات السريرية

References

DOI: 10.1177/1352458517751049

• Offer early treatment with DMDs to patients with active RRMS as defined by clinical relapses and/or MRI activity (active lesions–contrast-enhancing lesions; new or unequivocally enlarging T2 lesions assessed at least annually).
• Also includes CIS fulfilling current diagnostic criteria for MS.
• When treatment with a highly efficacious drug is stopped, either due to inefficacy or safety concerns, consider starting another highly efficacious drug.